Ta‐Wei Guu

717 total citations
17 papers, 296 citations indexed

About

Ta‐Wei Guu is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Ta‐Wei Guu has authored 17 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Biological Psychiatry and 3 papers in Pharmacology. Recurrent topics in Ta‐Wei Guu's work include Tryptophan and brain disorders (6 papers), Diet and metabolism studies (3 papers) and Bipolar Disorder and Treatment (3 papers). Ta‐Wei Guu is often cited by papers focused on Tryptophan and brain disorders (6 papers), Diet and metabolism studies (3 papers) and Bipolar Disorder and Treatment (3 papers). Ta‐Wei Guu collaborates with scholars based in Taiwan, United Kingdom and United States. Ta‐Wei Guu's co-authors include Kuan‐Pin Su, Jane Pei‐Chen Chang, Carmine M. Pariante, Kei Hamazaki, David Mischoulon, Yutaka Matsuoka, Felice N. Jacka, Wolfgang Marx, Robert H. Belmaker and Senthil Kumaran Satyanarayanan and has published in prestigious journals such as Journal of Affective Disorders, Brain Behavior and Immunity and Age and Ageing.

In The Last Decade

Ta‐Wei Guu

16 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ta‐Wei Guu Taiwan 9 89 83 80 55 38 17 296
Kyoko Hasebe Australia 11 65 0.7× 25 0.3× 97 1.2× 59 1.1× 23 0.6× 20 299
Rosemary Walker United States 4 86 1.0× 55 0.7× 150 1.9× 87 1.6× 26 0.7× 6 345
Tsung‐Tsair Yang Taiwan 10 77 0.9× 35 0.4× 58 0.7× 49 0.9× 18 0.5× 13 343
Huma Ikram Pakistan 12 63 0.7× 21 0.3× 61 0.8× 49 0.9× 27 0.7× 38 416
Jan K. van Niekerk United Kingdom 6 61 0.7× 55 0.7× 22 0.3× 118 2.1× 38 1.0× 7 329
Jean-François Costemale-Lacoste France 10 46 0.5× 20 0.2× 56 0.7× 27 0.5× 17 0.4× 17 287
Renata C.N. Marchette United States 10 117 1.3× 25 0.3× 25 0.3× 46 0.8× 24 0.6× 17 347
Franz Hozer France 8 41 0.5× 17 0.2× 84 1.1× 44 0.8× 16 0.4× 14 286
Walter Milano Italy 13 74 0.8× 35 0.4× 34 0.4× 29 0.5× 66 1.7× 32 445
Petra Suchankova Sweden 13 150 1.7× 156 1.9× 101 1.3× 89 1.6× 11 0.3× 16 513

Countries citing papers authored by Ta‐Wei Guu

Since Specialization
Citations

This map shows the geographic impact of Ta‐Wei Guu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ta‐Wei Guu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ta‐Wei Guu more than expected).

Fields of papers citing papers by Ta‐Wei Guu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ta‐Wei Guu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ta‐Wei Guu. The network helps show where Ta‐Wei Guu may publish in the future.

Co-authorship network of co-authors of Ta‐Wei Guu

This figure shows the co-authorship network connecting the top 25 collaborators of Ta‐Wei Guu. A scholar is included among the top collaborators of Ta‐Wei Guu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ta‐Wei Guu. Ta‐Wei Guu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Guu, Ta‐Wei, et al.. (2024). Wrist‐worn actigraphy in agitated late‐stage dementia patients: A feasibility study on digital inclusion. Alzheimer s & Dementia. 20(5). 3211–3218. 8 indexed citations
3.
Lee, Hsun‐Hua, et al.. (2024). Psychometric and structural properties of the traditional Chinese version of the sleep condition indicator for patients undergoing hemodialysis. Sleep And Breathing. 28(5). 2197–2204. 1 indexed citations
4.
Guu, Ta‐Wei, Paolo Cassano, Yi‐Ting Lin, et al.. (2024). Wearable, self-administered transcranial photobiomodulation for major depressive disorder and sleep: A randomized, double blind, sham-controlled trial. Journal of Affective Disorders. 372. 635–642. 5 indexed citations
5.
6.
Guu, Ta‐Wei, Dag Aarsland, & Dominic ffytche. (2023). Feasibility of Using Wearable Actigraphy for Behavioural Monitoring in Care Home Residents Living with Moderate to Severe Alzheimer’s Disease and Agitation. Alzheimer s & Dementia. 19(S19). 1 indexed citations
7.
Chang, Jane Pei‐Chen, Ta‐Wei Guu, Chih‐Kun Huang, et al.. (2023). Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients. Journal of Personalized Medicine. 13(6). 1003–1003. 8 indexed citations
8.
Guu, Ta‐Wei, Dag Aarsland, & Dominic ffytche. (2022). Light, sleep‐wake rhythm, and behavioural and psychological symptoms of dementia in care home patients: Revisiting the sundowning syndrome. International Journal of Geriatric Psychiatry. 37(5). 15 indexed citations
9.
Guu, Ta‐Wei, David Mischoulon, Jerome Sarris, et al.. (2020). A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders. 265. 233–238. 15 indexed citations
10.
Guu, Ta‐Wei, Hsueh‐Chou Lai, Cheng‐Yuan Peng, et al.. (2020). Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study. Brain Behavior & Immunity - Health. 2. 100035–100035. 6 indexed citations
11.
Sun, Ching-Fang, Wei‐Che Chiu, Pau‐Chung Chen, et al.. (2020). Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan. Brain Behavior and Immunity. 88. 125–131. 4 indexed citations
12.
Guu, Ta‐Wei, David Mischoulon, Jerome Sarris, et al.. (2019). International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychotherapy and Psychosomatics. 88(5). 263–273. 133 indexed citations
13.
Satyanarayanan, Senthil Kumaran, Jane Pei‐Chen Chang, Shih‐Yi Huang, et al.. (2019). Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety. Brain Behavior and Immunity. 85. 142–151. 48 indexed citations
14.
Chang, Jane Pei‐Chen, Ta‐Wei Guu, Yi‐Chih Chen, et al.. (2017). BanI polymorphism of cytosolic phospholipase A2 gene and somatic symptoms in medication-free acute depressed patients. Prostaglandins Leukotrienes and Essential Fatty Acids. 136. 111–115. 12 indexed citations
15.
Su, Kuan‐Pin, Hui-Ting Yang, Jane Pei‐Chen Chang, et al.. (2017). Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 80(Pt C). 227–233. 25 indexed citations
16.
Nishi, Daisuke, Kuan‐Pin Su, Kentaro Usuda, et al.. (2017). Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study. Nutritional Neuroscience. 22(1). 63–71. 5 indexed citations
17.
Nishi, Daisuke, Kuan‐Pin Su, Kentaro Usuda, et al.. (2016). The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial. BMC Psychiatry. 16(1). 321–321. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoko Hasebe Breakdown of academic impact, for papers by Rosemary Walker Breakdown of academic impact, for papers by Tsung‐Tsair Yang Breakdown of academic impact, for papers by Huma Ikram Breakdown of academic impact, for papers by Jan K. van Niekerk Breakdown of academic impact, for papers by Jean-François Costemale-Lacoste Breakdown of academic impact, for papers by Renata C.N. Marchette Breakdown of academic impact, for papers by Franz Hozer Breakdown of academic impact, for papers by Walter Milano Breakdown of academic impact, for papers by Petra Suchankova
Rankless by CCL
2026